达拉斯初创公司浓缩铀
Actinide is first startup to produce high-assay low-enriched uranium (HALEU)

原始链接: https://www.actinideinc.com/press/actinide-becomes-first-startup-to-ever-enrich-natural-uranium-to-produce-haleu

总部位于达拉斯的初创公司 Actinide 成为历史上首家利用自有专利技术生产出高丰度低浓缩铀(HALEU)的公司。通过使用现代高效电磁同位素分离器(卡留管),Actinide 成功将铀浓缩至 15.38%,绕过了传统离心法中复杂的转化瓶颈。 目前,美国在 HALEU 供应上严重依赖外国供应商,而 HALEU 是大多数先进核反应堆设计的必需品。虽然美国能源部长期垄断国内电磁同位素分离技术,但 Actinide 的技术提供了一种更快、更灵活且更具成本效益的替代方案。该公司的硬件可在数天内完成重组,以生产用于医疗、量子计算和能源领域的各种同位素,这标志着国内供应链能力发生了重大转变。 Actinide 由罗伯特·门德尔松(Robert Mendelsohn)和埃里克·奥尔谢夫斯基(Eric Olszewski)创立,目前正在开发其第二代系统“Fortitude”。预计这台先进机器的产能将接近联邦政府目前所有电磁分离设备总产能的一半,进一步巩固了该公司在保障美国战略材料独立性方面的作用。

初创公司 **Actinide** 因采用“电磁分离器”(calutron)技术——一种源自 1940 年代的电磁同位素分离方法——来生产高丰度低浓缩铀(HALEU)及镱-176 等浓缩同位素而备受关注。 Hacker News 上的讨论展现了两种截然不同的观点: * **商业实用性:** 支持者认为,尽管电磁分离器与现代离心机相比效率较低,但其模块化和较低的资本成本使其非常适合医疗同位素(如用于癌症治疗的同位素)的小批量生产。怀疑论者则认为,利用该技术进行大批量反应堆燃料生产是不切实际的,更有可能是“公关炒作”。 * **工程与核扩散:** 批评人士和工程师就技术挑战展开了辩论,例如设备内部的放射性污染问题以及该过程的高能耗特性。讨论的很大一部分集中在核不扩散问题上。虽然一些用户担心私营铀浓缩会缩短获取武器级材料的“突破时间”,但另一些人则认为,核政策更多地依赖于国际政治和监控,而非物理上的实施难度。 最终,观察人士认为该公司是对旧技术的一种有趣复兴,主要应用于专业化的小型医疗市场,而非对大规模核能领域的颠覆。
相关文章

原文

Dallas, TX, August 26 — Actinide, an advanced materials company that designs, builds, and operates its own isotope separation machines, has become the first startup in history to produce high-assay low-enriched uranium (HALEU). The enrichment was performed on the company's first-generation calutron, which, weeks earlier, was producing Actinide’s flagship commercial product: enriched ytterbium-176, delivered to Oklo Isotopes.

There is no end-to-end domestic supply chain for HALEU-based fuel: the Department of Energy says that most advanced reactor designs require HALEU, yet there is currently zero available from domestic suppliers. While conventional centrifuge enrichment is able to produce enriched uranium hexafluoride gas, this still must be converted into solid form before fuel fabrication - a process for which the United States has zero commercial capacity. The Department of Energy contracted six companies in 2024 to build out that deconversion capacity, but Actinide’s technology bypasses the bottleneck entirely by producing solid HALEU directly.

The HALEU was produced in research quantities under the laboratory-scale exclusion in NRC regulations, which carves out facilities used for experimental purposes only. U.S. law defines HALEU as uranium containing more than 5 percent but less than 20 percent uranium-235. An independent ISO/IEC 17025-accredited laboratory assayed the produced material at 15.38% enrichment. This material would still need to be fabricated into rods, pellets, or particles before a reactor could use it. 

“This demonstration is a testament to the power and flexibility of our technology. A centrifuge plant does one thing, costs billions, and takes years to stand up. Our machines cost a few hundred thousand dollars, produce material within months, deploy anywhere, and are able to be reconfigured in a matter of days to separate various isotopes as they are needed,” said Robert Mendelsohn, co-founder and CTO of Actinide.

Actinide’s first-generation calutron is a modern electromagnetic isotope separator that sorts atoms by mass inside a magnetic field. It builds on the same core principle used in the Manhattan Project calutrons at Oak Ridge’s Y-12, but the resemblance ends there. Modern magnets, vacuum systems, power electronics, and controls, refined by proprietary trade-secret advances, deliver the highest productivity of any calutron of its size ever constructed.

The United States built calutrons at Oak Ridge during the Manhattan Project and continued using some of them to supply stable isotopes for medicine, industry and research until 1998. The Department of Energy has since rebuilt federal electromagnetic-separation capacity and is expanding it, but the capability remains concentrated inside the government. America’s dependence extends to uranium enrichment: in 2025, 77% of the enrichment services purchased by U.S. civilian reactor owners came from foreign sources, including 26% from Russia, compared with 23% from American sources.

“America should not have to ask another country for the materials that determine whether a reactor runs or a cancer treatment gets made,” said Eric Olszewski, co-founder and CEO of Actinide.

The company is building Fortitude, its second-generation separator. On Actinide's engineering estimates, a single Fortitude machine would provide roughly half the isotope-separation capacity of the U.S. government's current electromagnetic fleet.

Actinide was founded in September 2025 after seven years of research and prototyping by Mendelsohn. Olszewski began financing the work before the company was incorporated, moved his family to Dallas in early 2024 to join Mendelsohn in the lab and invested more than $1 million of his own capital. Actinide raised an oversubscribed seed round in March 2026 led by Onto Ventures, with participation from Neo Ventures, Mana Ventures, Discipulus Ventures, Shor Capital, angel investors Ryan Hiepler, Stephen Cole, and others.

“Whether the application is nuclear energy, cancer medicine or quantum computing, the choke point is the same: access to the right isotope. And almost everyone attacking it is years from producing anything. Eric, Robert and the Actinide team designed and built their own separator, shipped material to a paying customer, and then made HALEU. They’re rebuilding America's isotope capacity and we’re proud to be on that journey with them." - Tom McQuillen, Onto Ventures

About Actinide

Actinide builds modern calutrons — electromagnetic isotope-separation machines — to produce atomically precise materials at scale. Using its first-generation calutron, Actinide has produced and sold ytterbium containing more than 95% ytterbium-176 and has enriched natural uranium into the HALEU range at research scale. Actinide is now building Fortitude, its second-generation system, to expand domestic production of materials required for medicine, nuclear energy, and advanced technologies. Founded in Dallas in September 2025, the company is on a mission to reshape the future of humanity, atom by atom.

联系我们 contact @ memedata.com